|
Journal |
|
|
|
Citation |
| |
J Biol Chem. 276(15):12190-200
|
|
|
Publication date |
|
|
|
Authors |
| |
Angelastro JM
Moon NY
Liu DX
Yang AS
Greene LA
Franke TF
|
|
|
Investigators |
|
|
|
Grant agencies |
|
|
|
Grants |
| |
NINDS NS16036
NINDS NS33689
|
|
|
MeSH headings |
|
|
|
MeSH qualifiers |
|
|
|
Abstract |
| |
We have identified a novel isoform of rat caspase-9 in which the C terminus of full-length caspase-9 is replaced with an alternative peptide sequence. Casp-9-CTD (where CTD is carboxyl-terminal divergent) is expressed in multiple tissues, with the relative highest expression observed in ovary and heart. Casp-9-CTD was found primarily in the cytoplasm and was not detected in the nucleus. Structural predictions suggest that in contrast to full-length caspase-9, casp-9-CTD will not be processed. Our model is supported by reduced protease activity of casp-9-CTD preparations in vitro and by the lack of detectable processing of casp-9-CTD proenzyme or the induction of cell death following transfection into cells. Both neuronal and non-neuronal cell types transfected with casp-9-CTD were resistant to death evoked by trophic factor deprivation or DNA damage. In addition, cytosolic lysates prepared from cells permanently expressing exogenous casp-9-CTD were resistant to caspase induction by cytochrome c in reconstitution assays. Taken together, our observations indicate that casp-9-CTD acts as a dominant-negative variant. Its expression in various tissues indicates a physiological role in regulating cell death.
|
|
|
Medline ID |
|
|
